Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo

Summary

A randomized clinical trial that treats vitiligo patients with oral vitamin D and Narrow-Band Ultraviolet B (NB-UVB) phototherapy (intervention group); or placebo and NB-UVB phototherapy (control group). We will evaluate if the group supplemented with vitamin D achieves a higher repigmentation rate than the control group, proving the relevance of vitamin D as an immunomodulator in the pathophysiology of vitiligo. These findings may support the use of vitamin D as an economic, safe, and adjuvant treatment for vitiligo.

Timeline

Start

2021-09-14

Primary completion

2022-02-25

Completion

2022-11-01

Drugs

Indications